Study S002185

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07228741
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: RECRUITING
Enrollment: 20
Start: 2026-04-23
Primary completion: 2027-11
Lead sponsor: St. Jude Children's Research Hospital
Conditions: Acute Lymphoblastic Leukemia; Obesity
Interventions: DRUG:Tirzepatide; BEHAVIORAL:Resistance Exercise; BEHAVIORAL:Lifestyle Counseling
Results posted: FALSE
Secondary identifiers: OTHER:NCI-2026-00106

Registered primary outcomes

To evaluate the effectiveness for weight loss of the combined intervention using once weekly Tirzepatide plus remote, supervised, tailored resistance exercise. [28 weeks (assessed baseline and Week 28)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.